Li-FT Power Ltd. has completed a C$23 million bought deal public offering, including full exercise of the over-allotment option, to support care and maintenance costs for the Renard option period and bolster working capital.
- Raised C$23 million through bought deal offering
- 7.935 million shares issued at C$2.90 each
- Full over-allotment option exercised
- Proceeds to fund Renard option care and maintenance
- Insider participation treated as related party transaction
Capital Raise Completes with Over-Subscription
Li-FT Power Ltd (ASX:LFT) has successfully closed its bought deal public offering, issuing 7.935 million common shares at C$2.90 apiece, generating gross proceeds of just over C$23 million. The deal included the full exercise of the underwriters’ over-allotment option, reflecting stronger-than-expected demand for the lithium miner’s equity.
The syndicate of underwriters was led by Canaccord Genuity Corp., with participation from BMO Capital Markets, Raymond James Ltd., ATB Cormark Capital Markets, and SCP Resource Finance LP. Underwriters earned a 5% cash commission on the gross proceeds, except for certain president’s list orders which attracted a reduced 2.5% commission.
Funds Directed to Renard Option and Working Capital
The net proceeds are earmarked primarily to cover care and maintenance costs during the first year of the Renard option period, as per the Renard option agreement, alongside general working capital needs. This aligns with Li-FT’s strategy to secure and prepare the Renard diamond mine site for potential lithium repurposing, a move that could leverage existing infrastructure to reduce capital expenditure on the company’s lithium projects.
Li-FT’s Renard option has been a focal point in recent months, with the company securing a two-year exclusive call option on the site, pending regulatory and court approvals. The care and maintenance costs covered by this raise are critical to preserving the asset while feasibility studies and regulatory processes advance.
Insider Participation and Regulatory Compliance
Notably, an executive of Li-FT participated in the offering, constituting a related party transaction under Canadian securities rules. The company secured exemptions from formal valuation and minority shareholder approval requirements, citing sound business reasons and timing constraints. Details of this insider participation will be disclosed in an upcoming material change report.
Li-FT’s securities remain unregistered in the United States and are not available for sale there except under specific exemptions, reflecting the company’s compliance with cross-border securities regulations.
Bottom Line?
The oversubscribed raise provides Li-FT with a solid financial runway to advance the Renard option, but upcoming disclosures on insider participation and the execution of care plans will be key to watch.
Questions in the middle?
- How will insider participation affect shareholder dynamics once fully disclosed?
- What progress will Li-FT make on regulatory approvals for the Renard option in the coming months?
- Will the company pursue further capital raises to support development beyond care and maintenance?